Acute Lung Injury Global Clinical Trials Review, H2, 2014

Date: October 31, 2014
Pages: 86
Price:
US$ 2,500.00 US$ 1,875.00
Offer valid until December 31, 2016!
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A8A006E3D4CEN
Leaflet:

Download PDF Leaflet

Acute Lung Injury Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Acute Lung Injury Global Clinical Trials Review, H2, 2014' provides data on the Acute Lung Injury clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acute Lung Injury. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Acute Lung Injury. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Copanies
Introduction
Acute Lung Injury
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Acute Lung Injury to Respiratory Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Acute Lung Injury to Respiratory Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of Acute Lung Injury
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Acute Lung Injury Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Acute Lung Injury
Aug 05, 2014: Silence Therapeutics Announces Publication of pre-clinical study data on use of Atu111 RNAi in sepsis
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Therametrics holding AG
Clinical Trial Overview of Therametrics holding AG
Altor BioScience Corporation
Clinical Trial Overview of Altor BioScience Corporation
SolAeroMed Inc.
Clinical Trial Overview of SolAeroMed Inc.
Faron Pharmaceuticals Oy
Clinical Trial Overview of Faron Pharmaceuticals Oy
Apeptico Forschung und Entwicklung GmbH
Clinical Trial Overview of Apeptico Forschung und Entwicklung GmbH
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
B. Braun Melsungen AG
Clinical Trial Overview of B. Braun Melsungen AG
APEIRON Biologics AG
Clinical Trial Overview of APEIRON Biologics AG
Abbott Laboratories
Clinical Trial Overview of Abbott Laboratories
Clinical Trial Overview of Top Institutes / Government
National Heart, Lung, and Blood Institute
Clinical Trial Overview of National Heart, Lung, and Blood Institute
Belfast Health and Social Care Trust
Clinical Trial Overview of Belfast Health and Social Care Trust
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
Vanderbilt University
Clinical Trial Overview of Vanderbilt University
Policlinico Hospital
Clinical Trial Overview of Policlinico Hospital
The Tel Aviv Sourasky Medical Center
Clinical Trial Overview of The Tel Aviv Sourasky Medical Center
University of Oklahoma
Clinical Trial Overview of University of Oklahoma
Boston Medical Center
Clinical Trial Overview of Boston Medical Center
Emory University
Clinical Trial Overview of Emory University
Medical University of Vienna
Clinical Trial Overview of Medical University of Vienna
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Acute Lung Injury Therapeutics, Global, Clinical Trials by Region, 2014
Acute Lung Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014
Acute Lung Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014
Acute Lung Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014
Acute Lung Injury Therapeutics Clinical Trials, Europe, Top Five Countries, 2014
Acute Lung Injury Therapeutics Clinical Trials, North America, Top Countries, 2014
Acute Lung Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014
Acute Lung Injury Therapeutics Clinical Trials, Central and South America, Top Countries, 2014
Proportion of Acute Lung Injury to Respiratory Clinical Trials, G7 Countries (%), 2014
Acute Lung Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2014
Acute Lung Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014
Proportion of Acute Lung Injury to Respiratory Clinical Trials, E7 Countries (%), 2014
Acute Lung Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2014
Acute Lung Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014
Acute Lung Injury Therapeutics, Global, Clinical Trials by Phase, 2014
Acute Lung Injury Therapeutics, Global, Clinical Trials In Progress by Phase 2014
Acute Lung Injury Therapeutics, Global, Clinical Trials by Trial Status, 2014
Acute Lung Injury Therapeutics Clinical Trials, Global, by End Point Status, 2014
Acute Lung Injury Therapeutics, Global, Suspended Clinical Trials, 2014
Acute Lung Injury Therapeutics, Global, Withdrawn Clinical Trials, 2014
Acute Lung Injury Therapeutics, Global, Terminated Clinical Trials, 2014
Acute Lung Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Acute Lung Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014
Acute Lung Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2014
Acute Lung Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014
Acute Lung Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014
Acute Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014
Acute Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Therametrics holding AG, 2014
Acute Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Altor BioScience Corporation, 2014
Acute Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by SolAeroMed Inc., 2014
Acute Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Faron Pharmaceuticals Oy, 2014
Acute Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Apeptico Forschung und Entwicklung GmbH, 2014
Acute Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014
Acute Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by B. Braun Melsungen AG, 2014
Acute Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by APEIRON Biologics AG, 2014
Acute Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014
Acute Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014
Acute Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Belfast Health and Social Care Trust, 2014
Acute Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014
Acute Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2014
Acute Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Policlinico Hospital, 2014
Acute Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by The Tel Aviv Sourasky Medical Center, 2014
Acute Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oklahoma, 2014
Acute Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Medical Center, 2014
Acute Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014
Acute Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014

LIST OF FIGURES

Acute Lung Injury Therapeutics, Global, Clinical Trials by Region (%), 2014
Acute Lung Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014
Acute Lung Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014
Acute Lung Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014
Acute Lung Injury Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014
Acute Lung Injury Therapeutics Clinical Trials, North America, Top Countries (%), 2014
Acute Lung Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014
Proportion of Acute Lung Injury to Respiratory Clinical Trials, G7 Countries (%), 2014
Acute Lung Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2014
Acute Lung Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014
Proportion of Acute Lung Injury to Respiratory Clinical Trials, E7 Countries (%), 2014
Acute Lung Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2014
Acute Lung Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014
Acute Lung Injury Therapeutics, Global, Clinical Trials by Phase (%), 2014
Acute Lung Injury Therapeutics, Global, Clinical Trials In Progress by Phase, 2014
Acute Lung Injury Therapeutics, Global, Clinical Trials by Trial Status, 2014
Acute Lung Injury Therapeutics Clinical Trials, Global, by End Point Status, 2014
Acute Lung Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Acute Lung Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014
Acute Lung Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2014
Acute Lung Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014
Acute Lung Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014
GlobalData Methodology
Skip to top


Acute Pain Global Clinical Trials Review, H1, 2016 US$ 2,125.00 Apr, 2016 · 282 pages
Lung Injury Global Clinical Trials Review, H2, 2015 US$ 2,000.00 Jul, 2015 · 80 pages
Acute Lung Injury - Pipeline Review, H1 2016 US$ 2,000.00 Jun, 2016 · 114 pages

Ask Your Question

Acute Lung Injury Global Clinical Trials Review, H2, 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: